REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

WuXi Biologics Cayman Inc. (Hong Kong SAR, China)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences
Full name: WuXi Biologics Cayman Inc. Profile Updated: March 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

WuXi Biologics Cayman Inc. engages in the provision of biologics services that offers comprehensive, integrated and highly customizable services to pharmaceutical and biotechnology companies. The company was founded in 2014 and is based in Shanghai, China.

Headquarters
No. 88 Meiliang West Road, Mashan
Wuxi; Jiangsu;

Contact Details: Purchase the WuXi Biologics Cayman Inc. report to view the information.

Website: http://www.wuxibiologics.com.cn

Basic Information
Total Employees:
Purchase the WuXi Biologics Cayman Inc. report to view the information.
Outstanding Shares:
Purchase the WuXi Biologics Cayman Inc. report to view the information.
Registered Capital:
Purchase the WuXi Biologics Cayman Inc. report to view the information.
Financial Auditors:
Purchase the WuXi Biologics Cayman Inc. report to view the information.
Incorporation Date:
2014
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Chief Technology Officer
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Ownership Details
Purchase this report to view the information.
15.15%
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Beijing Biologics (China)
100%
Biologics (Zhejiang) Co., Ltd (China)
100%
Biologics Biosafety Testing (Shanghai) Co., Ltd (China)
100%
Company Performance
Financial values in the chart are available after WuXi Biologics Cayman Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
11.56%▲
Total operating revenue
12.86%▲
Operating profit (EBIT)
-17.28%▼
EBITDA
-10.56%▼
Net Profit (Loss) for the Period
-21.52%▼
Total assets
14.15%▲
Total equity
21.55%▲
Operating Profit Margin (ROS)
-9.18%▼
Net Profit Margin
-8.84%▼
Return on Equity (ROE)
-4.45%▼
Debt to Equity Ratio
-1.85%▼
Quick Ratio
0.81%▲
Cash Ratio
0.59%▲

Similar companies

WuXi AppTec Co., Ltd. (Shanghai) (无锡药明康德新药开发股份有限公司 (上海))
 
BeiGene, Limited
3SBio Inc.
 
Genscript Biotech Corporation (Hong Kong) (金斯瑞生物科技股份有限公司 (香港))
Austar Lifesciences Limited
 
Shanghai Junshi Biosciences Company Limited
BBI Life Sciences Corporation (Hong Kong) (BBI生命科学有限公司 (香港))
 
Shandong Boan Biotechnology Company Limited
Ascentage Pharma Group International (Hong Kong) (亚盛医药集团-B (香港))
 
JW Cayman Therapeutics Company Limited

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo